Metallocenes as anti-tumor drugs
AssigneesTechnion Research & Development Foundation Limited, Ehud Keinan
InventorEhud Keinan
Life of this patent
Estimating the term…
Abstract
The invention relates to novel titanocene derivatives possessing chemotherapeutic activity and method for their preparation. These compounds possess two cyclopentadiene rings linked to titanium as a central atom and bound covalently to two phenoxy groups which possess a substituent R selected from the group consisting of COOCH.sub.3, COOC.sub.2 H.sub.5, H, COOCH.sub.2 CH.sub.2 OCH.sub.2 CH.sub.2 OCH.sub.3 and are free from amino, nitro, chloride and fluoride groups. The novel compounds represent a compromise between the main properties for an antitumor agent, i.e., electrophilicity and stability, being water soluble. Cytotoxicity measurements of these compounds showed significant growth inhibition properties, expressed in terms of IC.sub.50 [M] values.
Claims11
Novel titanocene derivatives which comprise two cyclopentadiene rings linked to titanium as a central atom, which are bound covalently to two phenoxy groups which possess a radical substituent R which is selected from the group consisting of:
- COOCH.sub.3, COOC.sub.2 H.sub.5, COOCH.sub.2 CH.sub.2 OCH.sub.2 CH.sub.2 OCH.sub.3,
- being free from amino group, nitro group, chloride and fluoride.
Bis(4-cyanophenolato)bis(n.sup.5 -cyclopentadienyl)titanium (IV).
Bis(4-methoxycarbonylphenolato)bis(n.sup.5 -cyclopentadienyl)titanium(IV).
Bis(4-ethoxycarbonylphenolato)bis(n.sup.5 -cyclopentadienyl)titanium(IV).
Bis(4-[2-(methoxyethoxy)ethoxy]carbonylphenolato)bis(n.sup.5 -cyclopentadienyl)titanium(IV).
Bis[4-(2-methoxy)ethoxycarbonylphenolato]bis(n.sup.5 -cyclopentadienyl)titanium(IV).
Bis[4-(2-dimethylamino)ethoxycarbonylphenolato]bis(n.sup.5 -cyclopentadienyl)titanium(IV).
Bis[4-(2-trimethylamino)ethoxycarbonylphenolato]bis(n.sup.5 -cyclopentadienyl)titanium(IV).
A method of treating tumors in a patient, which comprises administering to the patient an effective amount of a titanocene derivative comprising two cyclopentadiene rings linked to titanium as a central atom, which are bound covalently to two phenoxy groups which possess a radical substituent R selected from the group consisting of H, COOCH.sub.3, COOCH.sub.2 H.sub.5, and COOCH.sub.2 CH.sub.2 OCH.sub.2 CH.sub.2 OCH.sub.3 and are free from amino, nitro, chloride and fluoride groups.
A pharmaceutical preparation for treating tumors in a host which comprises a tumor-treating effective amount of one or more titanocene derivatives comprising two cyclopentadiene rings linked to titanium as a central atom, which are bound covalently to two phenoxy groups which possess a radical substituent R selected from the group consisting of H, COOCH.sub.3, COOCH.sub.2 H.sub.5, and COOCH.sub.2 CH.sub.2 OCH.sub.2 CH.sub.2 OCH.sub.3 and are free from amino, nitro, chloride and fluoride groups.
Dependencies are inferred from the claim text.